Wanyan Wang
Shanghai Key Laboratory Of New Drug Design
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Author Correction: PPIA dictates NRF2 stability to promote lung cancer progression.
Journal: Nature communications
Published: December 15, 2025
Berberrubine is a novel and selective IMPDH2 inhibitor that impairs the growth of colorectal cancer.
Berberrubine is a novel and selective IMPDH2 inhibitor that impairs the growth of colorectal cancer.
Journal: Biochemical pharmacology
Published: August 14, 2023
PPIA dictates NRF2 stability to promote lung cancer progression.
Journal: Nature communications
Published: May 18, 2023
Drug repurposing of ilepcimide that ameliorates experimental autoimmune encephalomyelitis via restricting inflammatory response and oxidative stress.
Journal: Toxicology and applied pharmacology
Published: June 19, 2022
Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine.
Journal: Frontiers in oncology
Published: March 24, 2021
A protein-fragment complementation assay reveals that celastrol and gambogic acid suppress ERα mutants in breast cancer.
Journal: Biochemical pharmacology
Published: January 15, 2021
Shikonin is a novel and selective IMPDH2 inhibitor that target triple-negative breast cancer.
Journal: Phytotherapy research : PTR
Published: March 02, 2020
Natural product piperine alleviates experimental allergic encephalomyelitis in mice by targeting dihydroorotate dehydrogenase.
Journal: Biochemical pharmacology
Published: February 20, 2020
Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely.
Journal: Bioorganic & medicinal chemistry
Published: August 08, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026